跳至主要内容
临床试验/NCT03006263
NCT03006263Enrolling By Invitation不适用

Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric Cancer

Fujian Medical University0 个研究点目标入组 110 人开始时间: 2016年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
110
主要终点
overall postoperative morbidity rates

研究概览

简要总结

The purpose of this study is to explore clinical outcomes of totally laparoscopic versus laparoscopy assisted total gastrectomy for gastric cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 to 75 years old
  • Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy
  • Locally advanced tumor in the middle third stomach(cT1-4a, N-/+, M0 at preoperative evaluation according to the AJCC(American Joint Committee on Cancer) Cancer Staging Manual Seventh Edition)
  • No distant metastasis, no direct invasion of pancreas, spleen or other organs nearby in the preoperative examinations
  • Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale
  • ASA (American Society of Anesthesiology) class I to III
  • Written informed consent

排除标准

  • Pregnant and lactating women
  • Suffering from severe mental disorder
  • History of previous upper abdominal surgery (except for laparoscopic cholecystectomy)
  • History of previous gastric surgery (including ESD/EMR (Endoscopic Submucosal Dissection/Endoscopic Mucosal Resection )for gastric cancer)
  • Enlarged or bulky regional lymph node (diameter over 3cm)supported by preoperative imaging including enlarged or bulky No.10 lymph node
  • History of other malignant disease within the past 5 years
  • History of previous neoadjuvant chemotherapy or radiotherapy
  • History of unstable angina or myocardial infarction within the past 6 months
  • History of cerebrovascular accident within the past 6 months
  • History of continuous systematic administration of corticosteroids within 1 month
  • Requirement of simultaneous surgery for other disease
  • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer
  • FEV1<50% of the predicted values

结局指标

主要结局

overall postoperative morbidity rates

时间窗: 30 days

Refers to the incidence of early postoperative complications. The early postoperative complication are defined as the event observed within 30 days after surgery.

次要结局

  • 3-year disease free survival rate(36 months)
  • Postoperative pain(30 days)
  • The variation of cholesterol(3, 6, 9 and 12 months)
  • The results of endoscopy(3 and 12 months)
  • The variation of body temperature(8 days)
  • 3-year recurrence pattern(36 months)
  • Time to first ambulation(30 days)
  • Time to first liquid diet(30 days)
  • The variation of white blood cell count(Preoperative 3 days and postoperative 1, 3, and 5 days)
  • Time to first soft diet(30 days)
  • The variation of C-reactive protein(Preoperative 3 days and postoperative 1, 3, and 5 days)
  • 3-year overall survival rate(36 months)
  • Intraoperative morbidity rates(1 day)
  • Time to first flatus(30 days)
  • Duration of postoperative hospital stay(30 days)
  • The variation of weight(3, 6, 9 and 12 months)
  • The variation of hemoglobin(Preoperative 3 days and postoperative 1, 3, and 5 days)

研究者

发起方
Fujian Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang-Ming Huang, Prof.

Professor

Fujian Medical University

相似试验